For its formulations manufacturing facility in Duvvada, Vishakhapatnam
Dr Reddys Laboratories announced that with regard to the audit conclusion of the Company's formulations manufacturing facility in Duvvada, Vishakhapatnam, by the Regulatory Authority of Germany, the CAPA plan submitted by the Company has been accepted by the Regulator. Consequently, the Regulator has permitted production to start again from this facility for the EU market. The Regulator will re-inspect this facility by end 2018.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
